Baxter International Inc. (NYSE:BAX), an innovator in connected beds for med-surg and the intensive care unit (ICU), announced today the U.S. launch of its new Hillrom Progressa+ bed for the ICU. Progressa+ offers new…
Novartis today announced that the U.S. District Court for the District of Delaware issued a negative decision regarding the validity of a patent covering Entresto and combinations of sacubitril and…
In the bustling city of Los Angeles, the Kaiser Permanente Los Angeles Medical Center has established itself as a beacon of hope, providing vital support to individuals battling addiction and…
We recognize July as Minority Mental Health Month and use it as an opportunity to educate and bring awareness. Historically marginalized communities across America face unique mental health challenges, and…
UnitedHealthcare Community Plan of Arizona has been awarded the industry-recognized Health Plan Accreditation and Long-Term Services and Supports (LTSS) Distinction by the National Committee for Quality Assurance (NCQA). NCQA accredits…
More than 2,800 attendees including pharmacists, independent pharmacy owners, technicians, exhibitors and McKesson experts came together last week at the 2023 McKesson ideaShare conference in Las Vegas. The annual event, which is…
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a once-weekly, human growth hormone analog…
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) for fidanacogene elaparvovec for the treatment of adults with…
MWI Animal Health, a part of AmerisourceBergen and a leading distributor of animal health products, today unveiled an updated and expanded version of its pet wellness web and mobile application…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved a new indication for PREVYMIS® (letermovir) for…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and the Canadian Cancer Trials Group (CCTG) today announced results from the Phase 3 CCTG IND.227/KEYNOTE-483 trial…
AstraZeneca and Merck (NYSE: MRK),known as MSD outside of the United States and Canada, today announced that LYNPARZA in combination with abiraterone and prednisone or prednisolone (abi/pred) has been approved…